# Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

> **NCT00227240** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 753 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00227240
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 753 (ACTUAL)
- **Last updated:** 2012-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227240, "Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00227240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*